All Stories

  1. Corrigendum to: Understanding and managing interferences in clinical laboratory assays: the role of laboratory professionals
  2. Automated Mindray CL-1200i chemiluminescent assays of renin and aldosterone for the diagnosis of primary aldosteronism
  3. Home pregnancy tests: quality first
  4. SARS-CoV-2 antibody performances: we need better criteria
  5. SARS-CoV-2 serosurvey in health care workers of the Veneto Region
  6. Evaluation of an ELISA for SARS-CoV-2 antibody testing: clinical performances and correlation with plaque reduction neutralization titer
  7. Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice
  8. SARS-CoV-2 RNA identification in nasopharyngeal swabs: issues in pre-analytics
  9. Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis
  10. Molecular diagnostics at the times of SARS-CoV-2 outbreak
  11. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics
  12. Quality controls for serology: an unfinished agenda
  13. Clinical laboratory and SARS-CoV-2 infection: where do we stand?
  14. New insights on the analytical performances for detecting and quantifying monoclonal proteins
  15. Measurement uncertainty: light in the shadows
  16. Understanding and managing interferences in clinical laboratory assays: the role of laboratory professionals
  17. Reflex TSH strategy: the good, the bad and the ugly
  18. Total testing process: roots and state-of-the-art
  19. Serum or plasma? An old question looking for new answers
  20. CCLM Award for the Most Cited Paper
  21. Blood biomarkers in neurology: “a call to arms” for laboratory professionals
  22. Professor Howard A. Morris
  23. The silk road to total quality in Laboratory Medicine
  24. Jillian Russyll (AKA Jill) Tate
  25. A pilot study for establishing quality indicators in molecular diagnostics according to the IFCC WG-LEPS initiative: preliminary findings in China
  26. System-related and cognitive errors in laboratory medicine
  27. Cigarette Smoking is Associated with Decreased Bone Gla-protein (BGP) Levels in Hemodialysis Patients
  28. Norbert Tietz, 13th November 1926–23rd May 2018
  29. Harmonization in laboratory medicine: Blowin’ in the wind
  30. Warfarin, but not rivaroxaban, promotes the calcification of the aortic valve in ApoE−/− mice
  31. Clinical laboratory: bigger is not always better
  32. Quality and future of clinical laboratories: the Vico’s whole cyclical theory of the recurring cycles
  33. Extra-analytical quality indicators – where to now?
  34. Laboratory-related errors: you cannot manage what you don’t measure. You manage what you know and measure
  35. Harmonization in laboratory medicine: more than clinical chemistry?
  36. Clinical Laboratory Medicine: An Alliance for the Optimal Management of Acute Kidney Injury with the Use of Biomarkers
  37. Massive Troponin Release and Normal Coronary Arteries: Where Does the Truth Lie?
  38. Analytical quality: an unfinished journey
  39. Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents
  40. Biomarkers of acute kidney injury: a step forward
  41. Diagnostic and prognostic value of low percentage of glycosylated ferritin in acquired hemophagocytic lymphohistiocytosis: A single-center study
  42. Biological variation of serum creatinine
  43. Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome
  44. High sensitivity cardiac troponin T in patients not having an acute coronary syndrome: results from the TRAPID-AMI study
  45. Quantitative Value of Aldosterone‐Renin Ratio for Detection of Aldosterone‐Producing Adenoma: The Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) Study
  46. Biological Variation Estimates Obtained from 91 Healthy Study Participants for 9 Enzymes in Serum
  47. Impaired Release of Vitamin D in Dysfunctional Adipose Tissue: New Cues on Vitamin D Supplementation in Obesity
  48. A note from the Editor in Chief regarding the Letter to the Editor “Great need for changes in higher education in Greece”
  49. A real-world evidence-based approach to laboratory reorganization using e-Valuate benchmarking data
  50. Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group “Laboratory Errors and Patient Safety” project
  51. ISO 15189 Accreditation: Navigation Between Quality Management and Patient Safety
  52. Mass spectrometry or immunoassay: est modus in rebus
  53. Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation
  54. Healthcare is a giant with feet of clay
  55. A Case of Atypical Urticaria
  56. Performance criteria and quality indicators for the post-analytical phase
  57. The quality indicator paradox
  58. Improving diagnosis and reducing diagnostic errors: the next frontier of laboratory medicine
  59. In Memoriam: Gérard Siest (1936–2016)
  60. The Choosing Wisely campaign – don’t throw the baby out with the bathwater
  61. The use of extra-analytical phase quality indicators by clinical laboratories: the results of an international survey
  62. CCLM Award for the Most Cited Paper Recently Published
  63. Towards a new paradigm in laboratory medicine: the five rights
  64. Corrigendum to: Performance criteria and quality indicators for the pre-analytical phase
  65. The standardization of the urine albumin assays: no longer deferrable
  66. Biological variation: back to basics
  67. Procalcitonin-guided antibiotic therapy: a potentially effective and efficient strategy
  68. Performance criteria and quality indicators for the pre-analytical phase
  69. Clinical laboratories: production industry or medical services?
  70. Evaluating and using innovative technologies: a lesson from Theranos?
  71. A new integrated tool for assessing and monitoring test comparability and stability
  72. Once upon a time: a tale of ISO 15189 accreditation
  73. Can biomarkers help us to better diagnose and manage sepsis?
  74. Asymmetric Dimethylarginine, Race, and Mortality in Hemodialysis Patients
  75. Appropriate labelling of blood collection tubes: a step ahead towards patient’s safety